During the past decade, Mount Kisco Medical Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 6 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mount Kisco Medical Group" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator, "ICR-CTSU" with 1 trials as a collaborator and "NCIC Clinical Trials Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Mount Kisco Medical Group" are "Metastatic Breast Cancer" (2 trials), "Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials), "Breast Neoplasms" (1 trials) and "Fallopian Tube Clear Cell Adenocarcinoma" (1 trials). Many other conditions were trialed in "Mount Kisco Medical Group" in a lesser frequency.

Most popular intervention types in "Mount Kisco Medical Group" are "Drug" (6 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "Cisplatin" (2 trials), "Laboratory Biomarker Analysis" (2 trials), "Placebo" (2 trials) and "Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mount Kisco Medical Group" are 4 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Mount Kisco Medical Group". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Mount Kisco Medical Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mount Kisco Medical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".